Articles científics publicats pels investigadors del Barcelonaβeta Brain Research Center (BBRC), relacionats amb la malaltia d'Alzheimer, la neuroimatge, la memòria i les malalties neurodegeneratives, entre altres camps.
Soldevila-Domenech N, Ayala-Garcia A, Zhou X, Yi SY, Ros E, Sala-Vila A, Lehtisalo J, Steffen LM, de la Torre R; IAFNS Retrospective Harmonization Expert Working Group; Blackwell CK, Khoo C, Mansolf MA, Ros E, Snetselaar L, Wey T.
Background: Cognitive decline is a major public health concern as populations age. Diet is a modifiable contributor to cognitive health, yet observational findings remain inconsistent, partly due to...
Pieperhoff L, Lorenzini L, Almeida F, Tranfa M, Bollack A, Arunachalam P, Masserini F, Wolz R, Grootoonk S, Ritchie C, Boada M, Marquié M, Vijverberg J, Vandenberghe R, Hanseeuw BJ, Martinez-Lage P, Payoux P, Visser PJ, Schöll M, Frisoni GB, Pardini M, Roccataglia L, Stephens AW, Buckley C, Farrar G, Jessen F, Gispert JD, Salvadó G, Luckett ES, Mutsaerts HM, Wink AM, Collij LE, Barkhof F, Oliveira TG; AMYPAD consortium.
Introduction: Early Alzheimer's disease (AD) involves subtle cortical changes that may precede atrophy. Magnetic resonance imaging (MRI) microstructural markers may detect earlier pathology than...
Gallay C, Soldevila-Domenech N, López-Martos D, Sanchez-Benávides G, Huguet J, Suárez-Calvet M, Gispert JD, Salvadó G, Sundermann EE, Grau-Rivera O, Brugulat-Serrat A; for ALFA study.
Background and objectives: Epidemiologic studies exploring the effect of parity on Alzheimer disease (AD) yield mixed results, and little is known about how parity may modify the impact of AD...
Vidal V, Farías G, Delgado C, Delano PH, Vergara RC, Orellana P, Ossandón T, Crossley NA, Gonzalez-Campo C, Naismith SL, Gonzalez-Gomez R, Coronel-Oliveros C, Ibáñez A, Wainstein G, Sanders RD, Shine JM, Medel V.
Introduction: White matter hyperintensities (WMHs) are a robust marker of brain aging and dementia risk, typically attributed to vascular pathology. However, impaired astrocytic support may also...
Farombi T, Azzi T, Legaz A, Aguillón D, Avila-Funes JA, Behrens MI, Bruno M, Cardona JF, Custodio N, Delgado C, Pina-Escudero S, Galofre MDPG, Maito M, Magrath-Guimet N, Miller JB, Matallana D, de Oliveira MO, Rocatti G, Resende EPF, Slachevsky A, Takada L, Wen O, Zapata-Restrepo LM, Lawlor B, Yaffe K, Hu K, Miller B, Possin K, Yokoyama JS, Fittipaldi S, García AM, Larzabal HH, Santamaria-Garcia H, Tagliazzuchi E, Duran-Aniotz C, Ibanez A, Migeot J.
Introduction: Adverse social conditions across the life course influence brain aging and dementia, yet their compounded impact on clinical phenotypes remains underexplored, particularly in Latin...
Quintero-Cardona P, Tangarife MA, Blandon J, Arango-Lasprilla JC, Ibanez A, Baez S.
Informal caregivers are central to dementia care in Latin America and the Caribbean (LAC), yet determinants of caregiver burden remain insufficiently characterized. We conducted a systematic review...
Pérez G, Caro I, Ponferrada J, Ferrante FJ, Valdés J, Migeot J, Welford AS, Olavarría L, Lillo P, Thumala-Dockendorff D, Okuma C, Cerda M, Henríquez F, Pelle P, Duran-Aniotz C, Ibáñez A, Ferrer L, Slachevsky A, García AM.
Verbal fluency tasks are ubiquitous in mild cognitive impairment (MCI) screenings. Yet, their assessment is traditionally limited to valid response counts. This subjective approach constrains analysis...
López-Martos D, Suárez-Calvet M, Salvadó G, Cacciaglia R, Shekari M, González-Escalante A, Horta-Barba A, Palma-Gudiel H, Milà-Alomà M, Brugulat-Serrat A, Minguillon C, Tonietto M, Borroni E, Klein G, Quijano-Rubio C, Kollmorgen G, Zetterberg H, Blennow K, Gispert JD, Sánchez-Benavides G, Grau-Rivera O; ALFA study.
Alzheimer's disease (AD) diagnostic guidelines emphasize subjective cognitive decline (SCD) preceding mild cognitive impairment (MCI), implicitly assuming awareness of cognitive decline (ACD) is...
Contador J, Pozzi FE, Sánchez-Benavides G, Fernández-Arcos A, Lantero-Rodríguez J, Montoliu-Gaya L, Minguillon C, Fauria K, González-Escalante A, Ortiz-Romero P, Blasco-Forniés H, de Diego-Osaba M, Jiménez Moyano E, Quijano-Rubio C, Kollmorgen G, Le Bastard N, Nadal A, Vanmechelen E, Jeromin A, Torres-Torronteras J, Ashton NJ, Zetterberg H, Blennow K, Gispert JD, Molinuevo JL, Del Campo M, Grau-Rivera O, Suárez-Calvet M; β-AARC Study collaborators.
Background: Subjective cognitive decline (SCD) may represent an early stage of Alzheimer's disease (AD), but biomarker studies in this population are limited. Therefore, we compared the performance of...
Eyre HA, Ayadi R, Ibáñez A, Rizig M, Fischer-Baum S.
N/A